Skip to main content
. 2021 Jul 7;66(2):304–314. doi: 10.1016/j.advms.2021.07.001

Fig. 3.

Fig. 3

Forest plot of studies reporting the proportion of patients with CK-MB concentrations above the normal range in COVID-19 patients with high severity or non-survivor status vs. those with low severity or survivor status during follow-up.